Entity Details

Primary name KPB2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP46019
EntryNameKPB2_HUMAN
FullNamePhosphorylase b kinase regulatory subunit alpha, liver isoform
TaxID9606
Evidenceevidence at protein level
Length1235
SequenceStatuscomplete
DateCreated1995-11-01
DateModified2021-06-02

Ontological Relatives

GenesPHKA2

GO terms

Show/Hide Table
GOName
GO:0004689 phosphorylase kinase activity
GO:0005516 calmodulin binding
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005964 phosphorylase kinase complex
GO:0005975 carbohydrate metabolic process
GO:0005980 glycogen catabolic process
GO:0006091 generation of precursor metabolites and energy
GO:0006464 cellular protein modification process

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR008734 Phosphorylase kinase alpha/beta subunitFamilyFamily
IPR008928 Six-hairpin glycosidase superfamilyFamilyHomologous superfamily
IPR011613 GH15-like domainDomainDomain
IPR012341 Six-hairpin glycosidase-like superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
306000 OMIMGlycogen storage disease 9A (GSD9A)A metabolic disorder resulting in a mild liver glycogenosis with clinical symptoms that include hepatomegaly, growth retardation, muscle weakness, elevation of glutamate-pyruvate transaminase and glutamate-oxaloacetate transaminase, hypercholesterolemia, hypertriglyceridemia, and fasting hyperketosis. Two subtypes are known: type 1 or classic type with no phosphorylase kinase activity in liver or erythrocytes, and type 2 or variant type with no phosphorylase kinase activity in liver, but normal activity in erythrocytes. Unlike other glycogenosis diseases, glycogen storage disease type 9A is generally a benign condition. Patients improve with age and are often asymptomatic as adults. Accurate diagnosis is therefore also of prognostic interest. The disease is caused by variants affecting the gene represented in this entry.